interleukin-1beta (163-171) has been researched along with sesquiterpenes in 1 studies
Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (sesquiterpenes) | Trials (sesquiterpenes) | Recent Studies (post-2010) (sesquiterpenes) |
---|---|---|---|---|---|
192 | 3 | 74 | 17,489 | 536 | 7,668 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castro, V; Klaas, CA; Koch, E; Merfort, I; Mora, G; RĂ¼ngeler, P; Vichnewski, W | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and sesquiterpenes
Article | Year |
---|---|
Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB.
Topics: Animals; B-Lymphocytes; Cell Division; Cytokines; Dose-Response Relationship, Drug; Interleukin-1; Interleukin-1beta; Interleukin-6; Lactones; Lymphocyte Activation; Male; Mice; NF-kappa B; Peptide Fragments; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2001 |